Press Release

CLINILABS RANKS NO. 2996 ON THE 2009 INC. 5000 WITH THREE-YEAR SALES GROWTH OF 92.5%

New York, NY (August 13, 2009) – Clinilabs, an early-phase and specialty contract research organization (CRO), is pleased to announce that it has been ranked No. 2996 on Inc. Magazine’s 2009 list of the 5000 fastest-growing private companies in America. Clinilabs posted a three-year sales growth of 92.5%. This is the second year in a row the Company has been ranked on this prestigious list of awardees.

The 2009 Inc. 5000 list takes a comprehensive look at America’s entrepreneurs and identifies leading companies based on revenue growth from 2005 through 2008. The 5000 companies that made the list this year reported combined revenue of $214 billion and a median increase in revenue of 126% over the past three years. In order to qualify for the list, companies must be US based, privately held and independent, and have had at least $200,000 in revenue in 2005, and $2 million in 2008.

“Clinilabs is privileged to be ranked on the Inc. 5000 list. This recognition truly belongs to our employees; those who have made our growth possible by dedicating themselves to delivering high quality, prompt, and cost effective clinical drug development services to the pharmaceutical industry,” stated Dr. Gary Zammit, Clinilabs’ President & CEO.

“Savvy trend spotters and those who invest in private companies know that the Inc. 5000 is the best place to find out about young companies that are achieving success through a wide variety of unprecedented business models, as well as older private companies that are still expanding at an impressive rate,” said Inc. 5000 project manager Jim Melloan. “That’s why our list is so eagerly anticipated every year.”

Clinilabs is a contract research organization that provides early phase and specialty clinical drug development services to industry. Since 2001, Clinilabs has worked for 9 of the top 20 pharma companies in the world, and 5 of the top ten CROs, to conduct over 170 clinical trials and contribute to 9 successful new drug applications (NDAs).


About Clinilabs Inc.

Clinilabs is a contract research organization (CRO) that provides early phase and specialty clinical drug development services to industry. Our organization offers clients a turn-key solution for single center and multicenter Phase I and II clinical trials. We also offer specialty drug development services in a variety of therapeutic areas. For more information, please visit www.clinilabs.com.

About Inc. Magazine

Founded in 1979 and acquired in 2005 by Mansueto Ventures LLC, Inc. (www.inc.com) is the only major business magazine dedicated exclusively to owners and managers of growing private companies that delivers real solutions for today’s innovative company builders. With a total paid circulation of 712,961, Inc. provides hands-on tools and market-tested strategies for managing people, finances, sales, marketing, and technology. Visit us online at Inc.com.

Contact:
Javier Folgar
Clinilabs Inc.
Tel. 646-215-6411
Fax. 646-215-6450
Email: jfolgar@clinilabs.com
Web: www.clinilabs.com